دورية أكاديمية
A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects.
العنوان: | A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects. |
---|---|
المؤلفون: | Xie S; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China.; Pharmaceutical College, Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China., Shi W; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China., Duan S; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China.; Department of Medicine, Guangxi University of Science and Technology, Liuzhou, Guangxi, 545005, P. R. China., Huang X; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China., Liu A; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China., Hou X; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China.; School of Basic Medical Science, Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China., Lin X; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China., Zhong D; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China., Sun S; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China., Ding Z; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China., Yang X; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China. yangxiaomei6009@sina.com.; School of Basic Medical Science, Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China. yangxiaomei6009@sina.com., Chen X; Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore. chen.shawn@nus.edu.sg., Lu X; Guangxi Key Laboratory of Nanobody Research, Guangxi Nanobody Engineering Research Center, College of Stomatology, Hospital of Stomatology Guangxi Medical University, Nanning, Guangxi, 530021, P. R. China. luxiaoling@gxmu.edu.cn. |
المصدر: | Journal of nanobiotechnology [J Nanobiotechnology] 2024 Sep 14; Vol. 22 (1), pp. 561. Date of Electronic Publication: 2024 Sep 14. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: London : BioMed Central, 2003- |
مواضيع طبية MeSH: | Single-Domain Antibodies*/chemistry , Single-Domain Antibodies*/immunology , T-Lymphocytes*/immunology , Indocyanine Green*/chemistry , Immunotherapy*/methods, Animals ; Mice ; Cell Line, Tumor ; Humans ; Neoplasms/therapy ; Neoplasms/immunology ; Female ; Mice, Inbred BALB C ; Photothermal Therapy/methods ; Liposomes/chemistry ; Lymphocyte Activation ; Mice, Inbred C57BL ; CD3 Complex/immunology |
مستخلص: | Background: T cell-based immunotherapies are facing great challenges in the recruitment and activation of tumor-specific T cells against solid tumors. Among which, utilizing nanobody (Nb) or nanobodies (Nbs) to construct T cell engager has emerged as a more practical potential for enhancing the anti-tumor effectiveness of T cells. Here, we designed a new Nb-guided multifunctional T cell engager (Nb-MuTE) that not only recruited effector T cells into the tumor tissues, but also efficiently activated T cells anti-tumor immunity when synergies with photothermal effect. Results: The Nb-MuTE, which was constructed based on an indocyanine green (ICG)-containing liposome with surface conjugation of CD105 and CD3 Nbs, and showed excellent targetability to both tumor and T cells, following enhancement of activation, proliferation and cytokine secretion of tumor-specific T cells. Notably, the immunological anti-tumor functions of Nb-MuTE-mediated T cells were further enhanced by the ICG-induced photothermal effect in vitro and in vivo. Conclusions: Such a new platform Nb-MuTE provides a practical and "all-in-one" strategy to potentiate T cell responses for the treatment of solid tumor in clinic. (© 2024. The Author(s).) |
References: | J Hematol Oncol. 2023 Nov 29;16(1):115. (PMID: 38031188) Signal Transduct Target Ther. 2023 Sep 4;8(1):328. (PMID: 37661200) United European Gastroenterol J. 2015 Oct;3(5):453-61. (PMID: 26535124) Natl Sci Rev. 2020 Jul 02;8(5):nwaa155. (PMID: 34691632) J Control Release. 2017 Dec 28;268:323-334. (PMID: 29107128) Nat Rev Drug Discov. 2019 Mar;18(3):197-218. (PMID: 30610226) Front Immunol. 2017 Nov 22;8:1603. (PMID: 29213270) Nat Methods. 2023 Jan;20(1):37. (PMID: 36635555) Biochim Biophys Acta. 1995 Jul 26;1237(2):99-108. (PMID: 7632714) J Nanobiotechnology. 2020 Jan 7;18(1):7. (PMID: 31910833) MAbs. 2021 Jan-Dec;13(1):1933690. (PMID: 34190031) Front Immunol. 2023 Jan 25;14:1012841. (PMID: 36761751) Tissue Eng Part A. 2014 Feb;20(3-4):553-65. (PMID: 24083839) Biomater Sci. 2020 Oct 7;8(19):5241-5259. (PMID: 32996922) J Mol Biol. 2001 Feb 2;305(5):989-1010. (PMID: 11162109) Ann Oncol. 2016 Aug;27(8):1482-92. (PMID: 27069014) JACC Cardiovasc Imaging. 2016 Sep;9(9):1087-1095. (PMID: 27544892) Nat Biomed Eng. 2021 Nov;5(11):1348-1359. (PMID: 34385695) J Nanobiotechnology. 2021 Oct 24;19(1):335. (PMID: 34689765) Adv Drug Deliv Rev. 2020;154-155:151-162. (PMID: 32926944) Lancet. 2023 Jul 8;402(10396):142-158. (PMID: 37271153) ACS Nano. 2019 Jan 22;13(1):386-398. (PMID: 30576599) Cancer Cell. 2020 Oct 12;38(4):454-472. (PMID: 32822573) Annu Rev Med. 2017 Jan 14;68:139-152. (PMID: 27860544) Nat Rev Clin Oncol. 2020 Nov;17(11):657-674. (PMID: 32699309) Molecules. 2020 Dec 01;25(23):. (PMID: 33271886) Mol Immunol. 2018 Apr;96:98-109. (PMID: 29549861) Neoplasia. 2008 Apr;10(4):380-9. (PMID: 18392137) Theranostics. 2018 Feb 2;8(5):1227-1242. (PMID: 29507616) Ann Surg. 2022 Jun 1;275(6):1025-1034. (PMID: 35121701) Nat Nanotechnol. 2024 Jun;19(6):818-824. (PMID: 38374413) Proc Natl Acad Sci U S A. 2023 Jun 13;120(24):e2216612120. (PMID: 37276407) Int J Nanomedicine. 2016 Jul 21;11:3287-303. (PMID: 27499623) Eur J Haematol. 2018 Dec;101(6):750-757. (PMID: 30187578) Int J Mol Sci. 2018 Dec 05;19(12):. (PMID: 30563158) N Engl J Med. 2023 Nov 30;389(22):2063-2075. (PMID: 37861218) Adv Mater. 2019 Jun;31(23):e1900192. (PMID: 30916367) Nat Rev Drug Discov. 2005 Feb;4(2):145-60. (PMID: 15688077) |
معلومات مُعتمدة: | No.2023GXNSFBA026178 Guangxi Natural Science Foundation Youth Fund Project of China; NUHSRO/2021/034/TRP/09/Nanomedicine NUS School of Medicine Nanomedicine Translational Research Programme; No. 82220108003 the International (Regional) Cooperation and Exchange Program of National Natural Science Foundation of China |
فهرسة مساهمة: | Keywords: Nanobody; Photothermal therapy; Solid tumor immunotherapy; T cell; T cell engager |
المشرفين على المادة: | 0 (Single-Domain Antibodies) IX6J1063HV (Indocyanine Green) 0 (Liposomes) 0 (CD3 Complex) |
تواريخ الأحداث: | Date Created: 20240913 Date Completed: 20240914 Latest Revision: 20240916 |
رمز التحديث: | 20240916 |
مُعرف محوري في PubMed: | PMC11401270 |
DOI: | 10.1186/s12951-024-02781-1 |
PMID: | 39272205 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1477-3155 |
---|---|
DOI: | 10.1186/s12951-024-02781-1 |